Indications linked with treatment of asthma will be changed

Inhaled steroids are preparations that are utilized in case of asthma by kids and adults. Individuals that experience mild, moderate and severe asthma apply these drugs each day. Inhaled steroids prevent inflammation of the airways. Health care providers supervise patients with this disease, regulating dosage schedule each 6 weeks.
Unfortunately, inhaled corticosteroids, like other medications, may cause adverse consequences. Regular administration of these medications is connected with certain risks. Is there any way for individuals with asthma to prevent these problems?
A recent study has manifested that prescribers should not recommend applying these drugs daily to persons with mild-to-moderate asthma. This research turned out to be very valuable. It is likely to alter instructions linked with treatment of asthma.
The study was conducted by scientists of the Texas Medical Brach in Galveston. Dr. William Calhoun and his colleagues enrolled 340 persons with asthma in the study. Several individuals received inhaled corticosteroids every day; others applied these preparations, when symptoms of asthma attacks appeared. Bronchial reactivity and functions of lungs were measured by the specialists during nine months. The results of the research demonstrated that there was not any significant difference between these two groups.
According to the specialists, if inhaled steroids are administered, when symptoms appear, exacerbation can be prevented. Moreover, these drugs have prolonged action. It means that positive effects are felt even several days after usage. The scientists suggest that these preparations may be used by individuals with mild-to-moderate asthma only when symptoms appear.
Why is this research valuable? According to certain sources, 25 million Americans suffer from asthma. Of course, they must be treated. This piece of news must be valuable for them. Furthermore, if inhaled steroids are administered prolonged time, they may lead to serious adverse reactions, such as hormonal imbalance, cataract, etc. Thus, if persons with mild-to-moderate asthma don’t administer these preparations each day, they are more unlikely to get these adverse effects.
Undoubtedly, it is early to alter guidelines linked with treatment of asthma. But this study may induce conducting further studies that may lead to some changes.